Paradromics acquires neuroscience AI startup Synaptiq to accelerate speech BCI decoding

Summary

Austin-based Paradromics announced the acquisition of Synaptiq AI, a 12-person startup specializing in neural signal processing and transformer-based sequence-to-sequence decoding for speech synthesis. The acquisition brings 4 machine learning PhDs and proprietary training data from 8 epilepsy monitoring unit patients onto Paradromics' speech BCI program.